Skip to content
Axe Capital logo Axe Capital Trading News

Axe Capital Investments

Clear market notes built around the JSE, the rand, and what matters locally.

Axe Capital Trading News shares simple market takes on the stories moving South African shares, the rand, and a handful of major currency pairs.

What you will find here:

1. JSE shares, South African companies, and the local knock-on effects of big market news.

2. The rand, interest rates, and a small group of forex pairs, with USD/ZAR at the centre.

3. Global stories only when they can actually change how a local investor might act.

Latest market stories

From 2009 to 2026 and Beyond, Apple Has Remained 1 of the Most Valuable Companies in the World: Here's the Most Important Takeaway for Investors
2026-10-16 18:00 • The Motley Fool Positive Axe Cap view: Selective

Apple has maintained its position as one of the world's most valuable companies at $5 trillion market cap, trailing only Nvidia. Despite taking a cautious approach to AI infrastructure spending compared to competitors, Apple's strong ecosystem, brand recognition, and iPhone dominance have enabled it to generate exceptional free cash flow of $110 billion while remaining competitive. The article argues Apple's economic moat is wider than perceived and the company can afford to integrate AI gradually without rushing.

Axe note: Apple’s steady free cash flow and ecosystem resilience set it apart in a noisy tech race.

Johnson & Johnson: 3 Key Takeaways for Long-Term Investors
2026-10-16 17:54 • The Motley Fool Positive Axe Cap view: Selective

Johnson & Johnson raised its full-year sales outlook after Q3 2026 operational revenue grew 6%, putting the company on track to exceed $100 billion in annual revenue for the first time. Strong pharmaceutical demand, particularly in cancer treatments, drove performance. However, the medical device segment faced headwinds with only 2.5% growth due to Middle East disruptions and China's bulk-buying program. Management plans to restore momentum through new product launches and is leaning toward spinning off its DePuy Synthes orthopedics subsidiary by mid-2027.

Axe note: JNJ’s strong pharma performance and strategic moves offer lessons for patient investors.

Why Bending Spoons Stock Soared 27% This Week
2026-10-16 17:39 • The Motley Fool Positive Axe Cap view: Selective

Bending Spoons stock surged 27% this week following a $330 million private placement investment from Berkshire Hathaway, expanding the investor's stake to roughly 4%. The capital injection supports the company's software roll-up strategy of acquiring and restructuring digital applications. However, the stock trades at elevated valuations (34x forward P/E) with significant debt of $5 billion, leaving little room for operational missteps.

Axe note: Berkshire Hathaway’s $330m investment pushed Bending Spoons shares up 27%, yet high debt and steep valuations warrant caution.

What we follow

We keep the focus on JSE shares, the rand, and the currency moves that matter most to South African investors.

JSE and rand